Core Viewpoint - The company Nanmo Biotechnology (688265.SH) announced a share transfer agreement involving significant shareholders due to funding needs, resulting in a change in ownership structure [1][2]. Group 1: Share Transfer Details - Shareholder Huirun Rongfeng will transfer 4,650,318 shares at a price of 27.369 CNY per share, representing 5.96% of the total share capital [1]. - Shareholder Kang Junningyuan will transfer 2,247,409 shares at the same price, representing 2.88% of the total share capital [1]. - Shareholder Zhangjiang Collective will transfer 1,782,000 shares at the same price, representing 2.29% of the total share capital [1]. Group 2: Post-Transfer Ownership Structure - After the transfer, Huirun Rongfeng and Zhangjiang Collective will no longer hold shares in the company, while Kang Junningyuan will hold 1,560,701 shares, representing 2.00% of the total share capital [2]. - Haowang Hezhong will hold 8,679,727 shares, representing 11.13% of the total share capital after the transfer [2].
南模生物(688265.SH):股东海润荣丰、康君宁元、张江集体签署股份转让协议